Antithrombotic Therapy Use at Discharge and 1 Year in Patients With Atrial Fibrillation and Acute Stroke
- 1 December 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 42 (12), 3477-3483
- https://doi.org/10.1161/strokeaha.111.625392
Abstract
Background and Purpose—: Current American Heart Association/American Stroke Association guidelines identify warfarin use as a class IA indication in patients with atrial fibrillation (AF) and ischemic stroke (IS) or transient ischemic attack (TIA). However, few studies have examined factors associated with long-term antithrombotic therapy use in IS/TIA patients with AF. Methods—: We utilized the Get With The Guidelines–Stroke national quality improvement registry and the Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry to examine patterns of antithrombotic use at discharge and at 12 months in IS/TIA patients with AF. A multivariate logistic regression model was developed to identify predictors of warfarin use in this patient population at 12 months. Results—: Of the 2460 IS/TIA patients, 291 (11.8%) had AF, of which 5.5% of patients were discharged on aspirin alone, 49.1% on warfarin alone, 1.4% on clopidogrel alone, 34.7% on warfarin plus aspirin, 2.1% on aspirin plus clopidogrel, and 1.0% on aspirin plus clopidogrel plus warfarin. Paradoxically, there was a decrease in the rate of warfarin use in patients with a CHADS 2 score >3. The only factor associated with warfarin use at 12-month follow-up was male gender (adjusted odds ratio, 2.27; confidence interval, 1.22–4.35; P =0.01). Conclusions—: Overall, the use of warfarin therapy is high at discharge in IS/TIA patients with AF; however, there was a decrease in the rate of warfarin use in patients with a CHADS 2 score >3. Compared to women, men were more likely to be on warfarin at 1 year after the index stroke event. Therefore, opportunities exist to improve antithrombotic use in all IS/TIA patients with AF.This publication has 33 references indexed in Scilit:
- Gender Differences in Acute Stroke TreatmentStroke, 2010
- The Role of Ethnicity, Sex, and Language on Delay to Hospital Arrival for Acute Ischemic StrokeStroke, 2010
- Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trialEuropean Heart Journal, 2009
- Quality of Care in Women With Ischemic Stroke in the GWTG ProgramStroke, 2009
- Gender Differences in Stroke Examined in a 10-Year Cohort of Patients Admitted to a Canadian Teaching HospitalStroke, 2008
- Risk of Myocardial Infarction or Vascular Death After First Ischemic StrokeStroke, 2007
- Guidelines for the Early Management of Adults With Ischemic StrokeStroke, 2007
- Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke PatientsStroke, 2006
- Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000Stroke, 2005
- Sex Differences in the Clinical Presentation, Resource Use, and 3-Month Outcome of Acute Stroke in EuropeStroke, 2003